Researchers explore the association between severe neonatal morbidity and maternal smoking before or during pregnancy.
ALK Inhibitor Outperforms Adjuvant Chemotherapy for Resected Lung Cancer
MADRID — Disease-free survival (DFS) in resectable ALK-positive non-small cell lung cancer (NSCLC) improved by 76% with adjuvant alectinib (Alecensa) compared with chemotherapy, according to